| ■ 영문 제목 : Global Isophane Insulin Injection Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00076 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 86 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 이소판인슐린 주사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (3ml/300유닛, 10ml/400유닛)와 용도별 시장규모 (경도 당뇨병 환자, 중증 당뇨병 환자) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 이소판인슐린 주사 시장 점유율 - 지역별 이소판인슐린 주사 시장규모 - 주요지역의 종류별 시장규모 (3ml/300유닛, 10ml/400유닛) - 주요지역의 용도별 시장규모 (경도 당뇨병 환자, 중증 당뇨병 환자) - 미주의 이소판인슐린 주사 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 이소판인슐린 주사 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 이소판인슐린 주사 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 이소판인슐린 주사 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 이소판인슐린 주사 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Ranbaxy Laboratories Ltd., Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd, Novo Nordisk Pharma lndia Ltd. - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Isophane Insulin Injection will have significant change from previous year. By the most conservative estimates of global Isophane Insulin Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Isophane Insulin Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Isophane Insulin Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by dosage: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
3ml/300Units
10ml/400Units
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
People With Mild Diabetes
Patients With Severe Diabetes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Ranbaxy Laboratories Ltd.
Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
Novo Nordisk Pharma lndia Ltd.
1 Scope of the Report 2 Executive Summary 3 Global Isophane Insulin Injection by Company 4 Isophane Insulin Injection by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Isophane Insulin Injection Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Isophane Insulin Injection Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of 3ml/300Units Table 3. Major Players of 10ml/400Units Table 4. Global Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses) Table 5. Global Isophane Insulin Injection Sales Market Share by Dosage (2016-2021) Table 6. Global Isophane Insulin Injection Revenue by Dosage (2016-2021) & ($ million) Table 7. Global Isophane Insulin Injection Revenue Market Share by Dosage (2016-2021) Table 8. Global Isophane Insulin Injection Sale Price by Dosage (2016-2021) Table 9. Global Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses) Table 10. Global Isophane Insulin Injection Sales Market Share by Application (2016-2021) Table 11. Global Isophane Insulin Injection Value by Application (2016-2021) Table 12. Global Isophane Insulin Injection Revenue Market Share by Application (2016-2021) Table 13. Global Isophane Insulin Injection Sale Price by Application (2016-2021) Table 14. Global Isophane Insulin Injection Sales by Company (2019-2021) & (K Doses) Table 15. Global Isophane Insulin Injection Sales Market Share by Company (2019-2021) Table 16. Global Isophane Insulin Injection Revenue by Company (2019-2021) ($ Millions) Table 17. Global Isophane Insulin Injection Revenue Market Share by Company (2019-2021) Table 18. Global Isophane Insulin Injection Sale Price by Company (2019-2021) Table 19. Key Manufacturers Isophane Insulin Injection Producing Area Distribution and Sales Area Table 20. Players Isophane Insulin Injection Products Offered Table 21. Isophane Insulin Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Isophane Insulin Injection Sales by Region (2016-2021) (K Doses) Table 25. Global Isophane Insulin Injection Sales Market Share by Region (2016-2021) Table 26. Global Isophane Insulin Injection Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Isophane Insulin Injection Revenue Market Share by Region (2016-2021) Table 28. Americas Isophane Insulin Injection Sales by Country (2016-2021) & (K Doses) Table 29. Americas Isophane Insulin Injection Sales Market Share by Country (2016-2021) Table 30. Americas Isophane Insulin Injection Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Isophane Insulin Injection Revenue Market Share by Country (2016-2021) Table 32. Americas Isophane Insulin Injection Sales by Type (2016-2021) & (K Doses) Table 33. Americas Isophane Insulin Injection Sales Market Share by Dosage (2016-2021) Table 34. Americas Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses) Table 35. Americas Isophane Insulin Injection Sales Market Share by Application (2016-2021) Table 36. APAC Isophane Insulin Injection Sales by Region (2016-2021) & (K Doses) Table 37. APAC Isophane Insulin Injection Sales Market Share by Region (2016-2021) Table 38. APAC Isophane Insulin Injection Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Isophane Insulin Injection Revenue Market Share by Region (2016-2021) Table 40. APAC Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses) Table 41. APAC Isophane Insulin Injection Sales Market Share by Dosage (2016-2021) Table 42. APAC Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses) Table 43. APAC Isophane Insulin Injection Sales Market Share by Application (2016-2021) Table 44. Europe Isophane Insulin Injection Sales by Country (2016-2021) & (K Doses) Table 45. Europe Isophane Insulin Injection Sales Market Share by Country (2016-2021) Table 46. Europe Isophane Insulin Injection Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Isophane Insulin Injection Revenue Market Share by Country (2016-2021) Table 48. Europe Isophane Insulin Injection Sales by Type (2016-2021) & (K Doses) Table 49. Europe Isophane Insulin Injection Sales Market Share by Dosage (2016-2021) Table 50. Europe Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses) Table 51. Europe Isophane Insulin Injection Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Isophane Insulin Injection Sales by Country (2016-2021) & (K Doses) Table 53. Middle East & Africa Isophane Insulin Injection Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Isophane Insulin Injection Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Isophane Insulin Injection Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Isophane Insulin Injection Sales by Dosage (2016-2021) & (K Doses) Table 57. Middle East & Africa Isophane Insulin Injection Sales Market Share by Dosage (2016-2021) Table 58. Middle East & Africa Isophane Insulin Injection Sales by Application (2016-2021) & (K Doses) Table 59. Middle East & Africa Isophane Insulin Injection Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Isophane Insulin Injection Table 61. Key Application and Potential Industries of Isophane Insulin Injection Table 62. Key Challenges of Isophane Insulin Injection Table 63. Key Trends of Isophane Insulin Injection Table 64. Isophane Insulin Injection Distributors List Table 65. Isophane Insulin Injection Customer List Table 66. Global Isophane Insulin Injection Sales Forecast by Region (2021-2026) & (K Doses) Table 67. Global Isophane Insulin Injection Consumption Market Forecast by Region Table 68. Global Isophane Insulin Injection Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Isophane Insulin Injection Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Isophane Insulin Injection Sales Forecast by Country (2021-2026) & (K Doses) Table 71. Americas Isophane Insulin Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Isophane Insulin Injection Sales Forecast by Region (2021-2026) & (K Doses) Table 73. APAC Isophane Insulin Injection Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Isophane Insulin Injection Sales Forecast by Country (2021-2026) & (K Doses) Table 75. Europe Isophane Insulin Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Isophane Insulin Injection Sales Forecast by Country (2021-2026) & (K Doses) Table 77. Middle East & Africa Isophane Insulin Injection Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Isophane Insulin Injection Sales Forecast by Dosage (2021-2026) & (K Doses) Table 79. Global Isophane Insulin Injection Sales Market Share Forecast by Dosage (2021-2026) Table 80. Global Isophane Insulin Injection Revenue Forecast by Dosage (2021-2026) & ($ Millions) Table 81. Global Isophane Insulin Injection Revenue Market Share Forecast by Dosage (2021-2026) Table 82. Global Isophane Insulin Injection Sales Forecast by Application (2021-2026) & (K Doses) Table 83. Global Isophane Insulin Injection Sales Market Share Forecast by Application (2021-2026) Table 84. Global Isophane Insulin Injection Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Isophane Insulin Injection Revenue Market Share Forecast by Application (2021-2026) Table 86. Ranbaxy Laboratories Ltd. Basic Information, Isophane Insulin Injection Manufacturing Base, Sales Area and Its Competitors Table 87. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Product Offered Table 88. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E) Table 89. Ranbaxy Laboratories Ltd. Main Business Table 90. Ranbaxy Laboratories Ltd. Latest Developments Table 91. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Basic Information, Isophane Insulin Injection Manufacturing Base, Sales Area and Its Competitors Table 92. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Product Offered Table 93. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E) Table 94. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Main Business Table 95. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Latest Developments Table 96. Novo Nordisk Pharma lndia Ltd. Basic Information, Isophane Insulin Injection Manufacturing Base, Sales Area and Its Competitors Table 97. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Product Offered Table 98. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E) Table 99. Novo Nordisk Pharma lndia Ltd. Main Business Table 100. Novo Nordisk Pharma lndia Ltd. Latest Developments List of Figures Figure 1. Picture of Isophane Insulin Injection Figure 2. Isophane Insulin Injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Isophane Insulin Injection Sales Growth Rate 2016-2026 (K Doses) Figure 7. Global Isophane Insulin Injection Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Isophane Insulin Injection Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of 3ml/300Units Figure 10. Product Picture of 10ml/400Units Figure 11. Global Isophane Insulin Injection Sales Market Share by Dosage in 2020 Figure 12. Global Isophane Insulin Injection Revenue Market Share by Dosage (2016-2021) Figure 13. Isophane Insulin Injection Consumed in People With Mild Diabetes Figure 14. Global Isophane Insulin Injection Market: People With Mild Diabetes (2016-2021) & (K Doses) Figure 15. Isophane Insulin Injection Consumed in Patients With Severe Diabetes Figure 16. Global Isophane Insulin Injection Market: Patients With Severe Diabetes (2016-2021) & (K Doses) Figure 17. Global Isophane Insulin Injection Sales Market Share by Application (2016-2021) Figure 18. Global Isophane Insulin Injection Revenue Market Share by Application in 2020 Figure 19. Isophane Insulin Injection Revenue Market by Company in 2020 ($ Million) Figure 20. Global Isophane Insulin Injection Revenue Market Share by Company in 2020 Figure 21. Global Isophane Insulin Injection Sales Market Share by Regions (2016-2021) Figure 22. Global Isophane Insulin Injection Revenue Market Share by Region in 2020 Figure 23. Americas Isophane Insulin Injection Sales 2016-2021 (K Doses) Figure 24. Americas Isophane Insulin Injection Revenue 2016-2021 ($ Millions) Figure 25. APAC Isophane Insulin Injection Sales 2016-2021 (K Doses) Figure 26. APAC Isophane Insulin Injection Revenue 2016-2021 ($ Millions) Figure 27. Europe Isophane Insulin Injection Sales 2016-2021 (K Doses) Figure 28. Europe Isophane Insulin Injection Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Isophane Insulin Injection Sales 2016-2021 (K Doses) Figure 30. Middle East & Africa Isophane Insulin Injection Revenue 2016-2021 ($ Millions) Figure 31. Americas Isophane Insulin Injection Sales Market Share by Country in 2020 Figure 32. Americas Isophane Insulin Injection Revenue Market Share by Country in 2020 Figure 33. Americas Isophane Insulin Injection Sales Market Share by Dosage in 2020 Figure 34. Americas Isophane Insulin Injection Sales Market Share by Application in 2020 Figure 35. United States Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Isophane Insulin Injection Sales Market Share by Region in 2020 Figure 40. APAC Isophane Insulin Injection Revenue Market Share by Regions in 2020 Figure 41. APAC Isophane Insulin Injection Sales Market Share by Dosage in 2020 Figure 42. APAC Isophane Insulin Injection Sales Market Share by Application in 2020 Figure 43. China Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 47. India Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Isophane Insulin Injection Sales Market Share by Country in 2020 Figure 50. Europe Isophane Insulin Injection Revenue Market Share by Country in 2020 Figure 51. Europe Isophane Insulin Injection Sales Market Share by Dosage in 2020 Figure 52. Europe Isophane Insulin Injection Sales Market Share by Application in 2020 Figure 53. Germany Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 54. France Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Isophane Insulin Injection Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Isophane Insulin Injection Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Isophane Insulin Injection Sales Market Share by Dosage in 2020 Figure 61. Middle East & Africa Isophane Insulin Injection Sales Market Share by Application in 2020 Figure 62. Egypt Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Isophane Insulin Injection Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 이소판인슐린 주사 시장예측 2021년-2026년] (코드 : LPI-2201K00076) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 이소판인슐린 주사 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |